Description
Rivaroxaban is a novel oral drug used to prevent blood clots from forming in adults who are having orthopedic surgery. It is a direct inhibitor of Factor Xa, an important cofactor in the blood coagulation process. Factor Xa’s ability to initiate the formation of thrombin, which is a vital step in the formation of blood clots, makes it an attractive target for anti-coagulant therapy.
Ingredients
Rivaroxaban
Drug Class
Factor Xa Inhibitors
Uses
Unveiling its multifaceted uses and transformative applications as follows:
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Prevention of DVT after hip or knee replacement surgery
- Prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (AF) with one or more risk factors
- Reduction of recurrence of acute venous sinus thrombosis (aVST)
Reviews
There are no reviews yet.